Patients’ co-payment
In the website of EOF, in the following link, has been uploaded the list of active substances and the relevant medicinal products included in the positive list and its supplement for which patients’ co-payment is 10% or 0% on the basis of the approved indications for the diseases according to article 38 Law 4025/2011 (O.J. 228 A’/2.11.2011) and the relevant Ministerial Decision Nr. Φ42000/οικ.2555/353 (O.J. 497 B’/28.2.2012). For the rest of the medicinal products included in the positive list, patients’ co-payment is 25%. For medicinal products of article 12 par. 2 Law 3816/2010 (serious diseases) there is no patients’ co-payment
